Echo Therapeutics, Inc. — Form D

Echo Therapeutics, Inc. of Iselin, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-08. The offering totals $6.0M, of which $1.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Elazer R EdelmanDirectorCambridge, MA
Michael M GoldbergDirectorIselin, NJ
Shepard M GoldbergDirectorIselin, NJ
Scott W HollanderDirectorIselin, NJ
Scott W HollanderExecutive OfficerIselin, NJ
Alan W SchoenbartExecutive OfficerIselin, NJ
Vincent D EnrightDirectorRye, NY
Robert LangerDirectorPittsburgh, PA
William GriecoDirectorAustin, TX
Patrick T MooneyDirectorHaddonfield, NJ
Patrick T MooneyExecutive OfficerHaddonfield, NJ
James SmithDirectorParker, CO
Patrick MooneyDirectorHaddonfield, NJ
Patrick MooneyExecutive OfficerHaddonfield, NJ
Shawn SinghDirectorHouston, TX
Shawn K SinghDirectorSouth San Francisco, CA
Walter WitoshkinDirectorSan Francisco, CA
Christopher SchnittkerExecutive OfficerCarneys Point, NJ
Robert DomanDirectorPhiladelphia, PA
Robert DomanExecutive OfficerPhiladelphia, PA
Kimberly BurkeExecutive OfficerPhiladelphia, PA
Vincent EnrightDirectorPhiladelphia, PA
James F SmithDirectorBellevue, NE
WILLIAM F GRIECODirectorFRANKLIN, MA
HARRY G MITCHELLExecutive OfficerFRANKLIN, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2013-12-19D$10.0M$10.0M
2011-02-15D$3.5M$3.5M
2011-02-15D/A$3.0M$2.9M
2010-11-05D$3.0M
2010-10-21D$5.0M$2.5M
2009-12-07D$563K$563K
2009-11-20D$3.6M$3.0M
2009-07-28D$2.0M$2.0M

More